Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mingmu Dihuang Pills
- Development stage
- Unknown
- Lead developer
- Lanzhou Foci
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Mingmu Dihuang Pills (Ming Mu Di Huang Wan) is a traditional Chinese medicine (TCM) formulation developed and marketed by Lanzhou Foci Pharmaceutical. It is a concentrated pill for oral administration, primarily indicated for nourishing the kidney and liver and improving vision. According to TCM principles, it is used to treat liver-kidney yin deficiency, which manifests as dry eyes, photophobia, blurred vision, and tearing when exposed to wind. The formulation is a complex herbal mixture containing twelve ingredients, including prepared rehmannia root, wolfberry, chrysanthemum, and abalone shell. It is listed as a National Essential Drug in China and is also marketed internationally as a dietary herbal supplement.
- Brand names
- Lanzhou Foci
- Other names
- Ming Mu Di Huang Wan明目地黄丸
02
Targets
AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)SRC (Proto-oncogene tyrosine-protein kinase Src)VEGFA (Vascular endothelial growth factor A)AMPK (Adenosine monophosphate–activated protein kinase)KEAP1 (Kelch-like ECH-associated protein 1)SQSTM1 (Sequestosome-1)
Beyond the preview
Go deeper on Mingmu Dihuang Pills.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mingmu Dihuang Pills.